Related Experiment Video
Updated: Dec 22, 2025

Continuous Video Electroencephalogram during Hypoxia-Ischemia in Neonatal Mice
Published on: June 11, 2020
Neonatal vitamin D status and risk of childhood epilepsy
Ina O Specht1, Fanney Thorsteinsdottir1, Karen Christina Walker1
1The Parker Institute, Research Unit for Dietary Studies, Bispebjerg and Frederiksberg Hospital, Frederiksberg, Denmark.
Insights
High neonatal vitamin D levels (25(OH)D3) are associated with an increased risk of childhood epilepsy. This suggests maternal vitamin D intake, not sun exposure, may play a role in epilepsy development.
Area of Science:
- Neurology
- Pediatrics
- Endocrinology
Background:
- Epilepsy is a neurological disorder with potential fetal origins.
- Vitamin D has shown neuroprotective effects in other neurological conditions.
- Seasonal birth variations in epilepsy suggest environmental influences.
Purpose of the Study:
- To investigate the association between neonatal 25(OH)D3 levels and the risk of childhood epilepsy.
- To determine if vitamin D exposure during fetal development impacts epilepsy risk.
Main Methods:
- A case-cohort study design was employed.
- Neonatal 25(OH)D3 levels were compared between children with epilepsy (n=403) and controls (n=1163).
- Weighted Cox proportional hazard models were used, adjusting for various covariates.
Main Results:
- Higher neonatal 25(OH)D3 levels showed a dose-response relationship with increased epilepsy risk (P-trend = .004).
- Children in the two highest quintiles of neonatal 25(OH)D3 had significantly higher adjusted hazard ratios for epilepsy.
- Results were robust even after adjusting for season of birth.
Conclusions:
- Elevated neonatal 25(OH)D3 is associated with a higher risk of childhood epilepsy.
- Maternal vitamin D intake, rather than sun exposure, appears to be the relevant source linked to epilepsy risk.
- Future research should explore compounds correlating with vitamin D in the fetal environment.
Objective:
Epilepsy is a nervous system abnormality that may be caused by unknown exposures during fetal development. Studies have shown neuroprotective effects of early exposure to vitamin D in other neurological disorders, and seasonal variation in birth of children with epilepsy. We aimed to investigate if neonatal 25(OH)D3 was associated with risk of childhood epilepsy.
Methods:
This case-cohort study compared neonatal 25(OH)D3 levels from children with epilepsy (n = 403) and a random selected cohort of controls (n = 1163), assessing the hazard of first epilepsy diagnosis between 1 and 4 years of age from a weighted Cox proportional hazard model. Analyses were adjusted for parental education, maternal age, maternal epilepsy, maternal ethnicity, and gestational age, and additionally for season of birth and smoking during pregnancy.
Results:
The mean (standard deviation [SD]) of neonatal 25(OH)D3 levels were 30.8(19.6) nmol/L among cases and 28.5(19.4) nmol/L among the cohort. The hazard ratio (HR) of epilepsy was in a dose-response pattern higher among children from the highest neonatal 25(OH)D3 quintiles (P-trend = .004). Results were unchanged after including season of birth in the analysis, where a significantly higher HR of epilepsy was observed among children in the two highest quintiles compared to children in the lowest quintile (Q4: HRadj 1.62, 95% CI 1.07-2.47 and Q5: HRadj 1.86, 95% CI 1.21-2.86).
Significance:
In this study, the risk of childhood epilepsy increased with neonatal 25(OH)D3 categories in a dose-response pattern, suggesting an association between a high neonatal 25(OH)D3 and the risk of childhood epilepsy. Considering that adjusting for season of birth strengthened the results, we conclude that maternal intake of vitamin D, and not vitamin D from sun exposure, was the vitamin D source associated with epilepsy. Although we cannot, in the present study, control for compounds in the diet like pollutants or heavy metals, which may correlate with dietary vitamin D, future studies investigating fetal origin of epilepsy should focus on compounds correlating with vitamin D.
More Related Videos
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion

